Top Markets
#1 Black Phoenix Black Phoenix +21,667.50%
#2 Nesa Nesa +771.34%
#3 Kinesis Silver Kinesis Silver +55.36%
#4 QuantixAI QuantixAI +23.76%
#5 Cash Cat Cash Cat +22.87%
#6 EXOD EXOD +22.78%
#7 Pons Pons +22.41%
#8 Alchemist AI Alchemist AI +16.62%
#9 Derive Derive +15.54%
#10 BNB Attestation Service BNB Attestation Service +15.18%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Inari Medical, Inc. Inari Medical, Inc.

Inari Medical, Inc.

NARI
Rank in Stocks #3846
Inari Medical, Inc. is a medical technology firm focused on creating,... Inari Medical, Inc. is a medical technology firm focused on creating, producing, promoting, and distributing devices for the minimally invasive management of venous conditions within the United States. Their product portfolio includes ClotTriever, a mechanical thrombectomy solution designed to extract significant clots from major blood vessels, specifically targeting deep vein thrombosis. Another key offering is FlowTriever, a substantial catheter-based aspiration and mechanical thrombectomy system, which addresses pulmonary embolism. The company also provides FlowSaver; FlowStasis, a large-bore suture retention device to manage venous access points; and FlowTriever 2, an enhanced version with a new disk design for efficiently capturing wall-adherent clots and reducing procedure time. Founded in 2011, the company was initially known as Inceptus Newco1 Inc. before rebranding as Inari Medical, Inc. in September 2013. Its corporate headquarters are located in Irvine, California.
Share Price
$79.97
Last synced: 2025-02-19
Market Cap
$4.57B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Inari Medical, Inc. (NARI)

Category

Healthcare
Revenue for Inari Medical, Inc. (NARI)
Revenue in Sep 2024 TTM: $574.50M
According to Inari Medical, Inc. latest financial reports the company's current revenue (TTM) is $574.50M. In 2022 the company made a revenue of $383.47M an increase over the revenue in the year 2021 that was $276.98M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Inari Medical, Inc. from 2018 to 2026
Revenue at the end of each year
Year Revenue Change
2026 (TTM) $574.50M 16.38%
2023 $493.63M 28.73%
2022 $383.47M 38.45%
2021 $276.98M 98.31%
2020 $139.67M 173.17%
2019 $51.13M 648.70%
2018 $6.83M 0.00%
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B 8,008.82%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B 4,397.32%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B 6,076.52%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B 3,554.67%
US
Siemens Healthineers AG Siemens Healthineers AG
Siemens Healthineers AG
SHL.DE
 - -
DE